This analysis examined the efficacy of fidaxomicin versus vancomycin in 406 canadian patients with clostridium difficile infection cdi, based. Fidaxomicin for clostridium difficile infection nejm. Fidaxomicin compared with vancomycin and metronidazole for. The most widely used antibiotics for the management of cdi are vancomycin vcm and metronidazole. Watt m, mccrea c, johal s, posnett j, nazir j, et al. Researchers compare vancomycin and fidaxomicin according to research published in the lancet infectious diseases extend study, researchers compared the effectiveness of a novel fidaxomicin antibiotic. Fidaxomicin versus vancomycin for infection with clostridium difficile in europe, canada, and the usa. Fidaxomicin versus vancomycin for clostridium difficile infection. Fidaxomicin therapy significantly reduces the rate of recurrence and significantly increases the rate of global cure of c. Effectiveness of fidaxomicin versus vancomycin for clostridium difficile treatment. Although there is debate surrounding the relative importance of metronidazole and vancomycin in. Treatment and prevention of clostridioides difficile infections.
Gorbach 8 st joseph s healthcare, mcmaster university, hamilton, on, canada royal jubilee hospital, island health. This analysis examined the efficacy of fidaxomicin versus vancomycin in 406 canadian patients with clostridium difficile infection cdi, based on data from 2 randomized, clinical trials. Pdf fidaxomicin versus vancomycin for clostridium difficile infection. Treatment and prevention of clostridioides difficile. Clinical study fidaxomicin versus vancomycin in the treatment of clostridium difficile infection. Of 535 patients enrolled, 270 were assigned fidaxomicin and 265 vancomycin. Current and emerging management options for clostridium difficile. The incidence of clostridium difficile c difficile infection cdi in the u. Fidaxomicin dificid for clostridium difficile infection steps. Clinical study fidaxomicin versus vancomycin in the treatment. Fidaxomicin vs vancomycin for the treatment of a first episode of.
Fidaxomicin is roughly eighttimes more potent in vitro than is vancomycin against clinical isolates of c difficile, including nap1bi027. Pdf clostridium difficile infection is a serious diarrheal illness associated with substantial morbidity and mortality. Poor outcomes following clostridium difficile infection cdi have been associated with advanced age, presence of cancer and c. Fidaxomicin versus vancomycin for clostridium difficile infection thomos j. Significantly fewer patients in the fidaxomicin group than in the vancomycin group had a recurrence of the infection, in both the modified intentiontotreat analysis 15. Background clostridium difficile colitis cdiff usually develops after broad spectrum antibiotic exposure. Fidaxomicin versus vancomycin for clostridium difficile. This analysis examined the efficacy of fidaxomicin versus vancomycin in 406 canadian patients with clostridium difficile infection cdi, based on. In both studies, adults with active cdi were randomized to receive blinded fidaxomicin 200 mg twice daily or vancomycin 125 mg 4 times a day for 10 days.
Clostridium difficile infection cdi, also known as c. We performed a singlecenter randomized trial to compare the effects of fmt with those of fidaxomicin and vancomycin. Fidaxomicin is noninferior to vancomycin in achieving clinical cure of c. Current health protection agency hpa guidance recommends metronidazole as firstline therapy in mild to moderate cdi, but vancomycin in. Mar 25, 2019 poor outcomes following clostridium difficile infection cdi have been associated with advanced age, presence of cancer and c. Safety and efficacy of fidaxomicin in patients with. Treatment of first recurrence of clostridium difficile infection. Fidaxomicin has previously been found noninferior to the use of oral. Clostridioides clostridium difficile infection cdi is the leading cause of nosocomial bacterial diarrhoea in industrialised countries, and can be serious and lifethreatening.
Clostridium difficile and fidaxomicin mag online library. Fidaxomicin vs vancomycin for clostridium difficile infection. Fidaxomicin versus oral vancomycin for severe clostridium. Both agents are recommended in the current treatment guidelines issued by the european society of clinical microbiology and infectious diseases escmid. The impact of baseline risk factors on clinical outcomes was evaluated using data from the extend study, in which rate of sustained clinical cure scc in the overall population was significantly higher with an extendedpulsed fidaxomicin. Louie, 3 karlweiss, 4 louisvaliquette, 5 marvingerson, 6 wendyarnott, 7 andsherwoodl. In summary, fidaxomicin was shown to be noninferior to vancomycin in achieving clinical cure of c. Oral vancomycin for clostridium difficile infection in patients with spinal cord injury. Efficacy of fidaxomicin versus vancomycin as therapy for. We used the following keywords in different combinations.
Listing a study does not mean it has been evaluated by the u. Fidaxomicin versus vancomycin article pdf available in clinical infectious diseases 55 suppl 2suppl 2. May 01, 2018 a randomized, controlled, openlabel clinical trial conducted at 86 european hospitals that included adults aged 60 years or older found that extendedpulsed dosing of fidaxomicin was superior to standarddose vancomycin for sustained cure of clostridium difficile infection and resulted in fewer disease recurrences. Only minimal systemic absorption occurs following oral administration. Fidaxomicin versus vancomycin for clostridium difficile infec tion. Fidaxomicin versus vancomycin in the treatment of clostridium. Clostridium difficile infection cdi has been increasing in both severity and incidence 1, 2. Fidaxomicin compared with oral vancomycin for the treatment of severe clostridium difficileassociated diarrhea. Fidaxomicin vs vancomycin for clostridium difficile. Pdf costeffectiveness analysis of fidaxomicin versus. Clostridium difficile infection causes severe complications and frequently recurs. Fidaxomicin dificid for clostridium difficile infection. The previous guidelines recommended metronidazole as the firstline therapy for initial cases of mildtomoderate cdis and vancomycin for more severe cases.
Fidaxomicin versus vancomycin for the treatment of. Two recently completed phase 3 trials 003 and 004 showed fidaxomicin to be noninferior to vancomycin for curing clostridium difficile infection cdi and. Feb 01, 20 fidaxomicin versus vancomycin for infection with clostridium difficile in europe, canada, and the usa. Two phase 3 randomized, doubleblind trials were conducted at 154 sites in the united states, canada, and europe to compare fidaxomicin vs vancomycin in treating cdi. Symptoms include watery diarrhea, fever, nausea, and abdominal pain. Fidaxomicin is a macrolide antibiotic approved by the food and drug administration fda for treatment of c. In a subanalysis of individuals that developed acute graft versus host disease following cdi, the difference in mean onset of acute graft versus host disease was 21. Williams ii 1 1 pharmacy service, oklahoma city va health care system, oklahoma city, ok, usa 2 medical service, oklahoma city va health care system, oklahoma city, ok, usa.
Randomized cunical trial rct in clostridium difficile infection cdi confirms equivalent cure rate and lower recurrence rate of fidaxomicin fdx versus vancomycin vcn. Use of metronidazole and oral vancomycin has been associated with clinical failure. Treatment with fidaxomicin resulted in significantly higher rates of resolution of diarrhea without recurrence than did treatment with vancomycin. Between 2030% of patients who experience an initial episode of c. It primarily exhibits activity against species of clostridia. Original article fidaxomicin versus oral vancomycin for severe clostridium dif. The authors also reported significantly fewer recurrences of infection, a frequent problem with c. Fidaxomicin versus vancomycin for infection with clostridium. Patients were assessed for clinical response recurrence of infection and sustained clinical response for 28 days after. Retrospective evaluation of fidaxomicin versus oral. Fidaxomicin was shown to be as good as the standardofcare, vancomycin, for treating clostridium difficile infection in a phase iii trial published in february 2011. Dec 21, 2018 fidaxomicin versus vancomycin for infection with clostridium difficile in europe, canada, and the usa. Fecal microbiota transplantation fmt is recommended for treatment of recurrent clostridium difficile infection rcdi. Treatment of first recurrence of clostridium difficile.
Fidaxomicin pharmacokinetics absorption bioavailability. Fecal microbiota transplantation is superior to fidaxomicin. Two recently completed phase 3 trials 003 and 004 showed fidaxomicin to be noninferior to vancomycin for curing clostridium difficile infection cdi and superior for reducing cdi recurrences. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.
It makes up about 20% of cases of antibioticassociated diarrhea. After 26 patients were excluded, 509 were included in the modified intentiontotreat mitt population. Fidaxomicin use and clinical outcomes for clostridium diffic. Extendedpulsed fidaxomicin versus vancomycin for clostridium. Extendedpulsed fidaxomicin versus vancomycin for clostridium difficile infection in patients 60 years and older extend. Rates of recurrence were significantly lower in the fidaxomicin group when compared with the vancomycin group 15. Pdf fidaxomicin versus vancomycin in the treatment of. An extendedpulsed fidaxomicin regimen might facilitate sustained clinical cure by. Clostridium difficile infection usually responds to metronidazole or vancomycin, 1 however up to a third of patients have recurrent infection. Fidaxomicin for the treatment of clostridium difficile. In their randomized study comparing fidaxomicin with vancomycin for clostridium difficile infection, louie et al. Clostridioides difficile infection cdi or cdiff, also known as clostridium difficile infection, is a symptomatic infection due to the sporeforming bacterium clostridioides difficile. Clostridium difficile, clostridium difficile infection, cdi, c. Costeffectiveness analysis of fidaxomicin versus vancomycin.
Fidaxomicin compared with oral vancomycin for the treatment. Fidaxomicin is a narrow spectrum macrocyclic antibiotic with bactericidal activity against c. Patients were assessed for clinical response recurrence of infection and sustained clinical response for 28 days after treatment completion. This phase 3 clinical trial compared the efficacy and safety of fidaxomicin with those of vancomycin in treat ing c. Clostridium difficile infection cdi is a potential complication during hematopoietic stem cell transplantation hsct, and no specific recommendations exist regarding treatment of cdi in allogeneic sct patients. Recurrence of clostridium difficile infection cdi occurs in approximately 25% of successfully treated patients. Effectiveness of fidaxomicin versus vancomycin for. Dec, 2011 study applications this study aided in the fda decision for approval of fidaxomicin dificid in may 2011 proving noninferiority, fidaxomicin provides a reasonable alternative to vancomycin in the treatment of clostridium difficile associated diarrhea in the future currently being investigated are new indications for the drug and an. Jul, 2012 fidaxomicin dificlir is the first in a new class of macrocylic antibiotics and has recently been licensed by the european medicines agency ema for the treatment of clostridium difficile infection cdi.
Costeffectiveness analysis of fidaxomicin versus vancomycin in clostridium difficile infection. The recommended adult dose is 200 mg twice daily for 10 days. Clinical study fidaxomicin versus vancomycin in the. For the past 30 years, the antibiotic treatment of clostridium difficile infection cdi has depended primarily on metronidazole and vancomycin. This study was conducted to compare clinical outcomes of. The role of fidaxomicin in clostridium difficile infection. Fid i i v i f fidaxomicin vs vancomycin for clostridium difficile infection geriatric grand rounds journal club 92112 carly lam m.
680 401 1496 484 845 605 521 548 1048 1391 168 154 820 244 1141 975 1138 1208 304 402 1179 130 660 1214 1267 486 113 48 1147 493 1297